Skip to Content
주식/증권 📈 긍정적

LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?

요약

Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.